Applied Therapeutics Inc. has entered into a Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co., allowing the company to offer and sell up to $75 million worth of its common stock. The shares will be sold through the agent, Cantor Fitzgerald, under a shelf registration statement filed with the SEC. The agreement includes customary indemnification and a commission of 3.0% of the aggregate gross proceeds from the sales. This development follows the termination of a previous sales agreement with Leerink Partners LLC, which was effective on the same date.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Applied Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-112224), on August 29, 2025, and is solely responsible for the information contained therein.